Abstract
Since our review in Current Organic Chemistry in 1997 (Curr. Org. Chem. 1997, 1, p. 307-344), important advances have been made in the field of natural products antiviral research. Therefore, we provide here a comprehensive review of the latest developments on plant substances as antiviral agents. The review is mainly focused on plant-derived substances with an anti-human immunodeficiency virus (anti-HIV) and an anti-herpes simplex virus (anti-HSV) activity. The anti-HIV activity of the plant substances is discussed according to their mechanism of action, targeting the critical steps of the HIV replicative cycle, i.e. adsorption, virus-cell fusion, virus uncoating, reverse transcription, integration, proviral DNA transcription, transcription, translation, assembly, and budding. Some of the anti-HIV active compounds show also immune stimulating properties, which can provide an additional benefit in the treatment of AIDS. The anti-HSV activities of the plant substances are discussed according to their in vitro and in vivo activity against HSV-1 and HSV-2, including acyclovir-resistant strains, and where relevant, their activity against cytomegalovirus is mentioned. Finally, the antiviral activities of plant substances against the influenza virus are briefly outlined.
Keywords: anti-HIV, influenza, cytomegalovirus
Current Organic Chemistry
Title: Plant Substances as Antiviral Agents: An Update (1997-2001)
Volume: 7 Issue: 12
Author(s): P. Cos, D. Vanden Berghe, T. De Bruyne and A. J. Vlietinck
Affiliation:
Keywords: anti-HIV, influenza, cytomegalovirus
Abstract: Since our review in Current Organic Chemistry in 1997 (Curr. Org. Chem. 1997, 1, p. 307-344), important advances have been made in the field of natural products antiviral research. Therefore, we provide here a comprehensive review of the latest developments on plant substances as antiviral agents. The review is mainly focused on plant-derived substances with an anti-human immunodeficiency virus (anti-HIV) and an anti-herpes simplex virus (anti-HSV) activity. The anti-HIV activity of the plant substances is discussed according to their mechanism of action, targeting the critical steps of the HIV replicative cycle, i.e. adsorption, virus-cell fusion, virus uncoating, reverse transcription, integration, proviral DNA transcription, transcription, translation, assembly, and budding. Some of the anti-HIV active compounds show also immune stimulating properties, which can provide an additional benefit in the treatment of AIDS. The anti-HSV activities of the plant substances are discussed according to their in vitro and in vivo activity against HSV-1 and HSV-2, including acyclovir-resistant strains, and where relevant, their activity against cytomegalovirus is mentioned. Finally, the antiviral activities of plant substances against the influenza virus are briefly outlined.
Export Options
About this article
Cite this article as:
Cos P., Berghe Vanden D., Bruyne De T. and Vlietinck J. A., Plant Substances as Antiviral Agents: An Update (1997-2001), Current Organic Chemistry 2003; 7 (12) . https://dx.doi.org/10.2174/1385272033486558
DOI https://dx.doi.org/10.2174/1385272033486558 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Current Cardiology Reviews Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Current Drug Metabolism Viral and Cellular Cytokines as Therapeutic Targets in AIDS-Related Lymphoproliferative Disorders
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial [ The Wide Roles of Cytokines During Evolution Executive Editors: M. de Eguileor and E. Ottaviani ]
Current Pharmaceutical Design Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Current Diabetes Reviews mTOR, a Potential Target to Treat Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Physiological Basis for Contractile Dysfunction in Heart Failure
Current Pharmaceutical Design Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets Genome-wide Analysis of Myelodysplastic Syndromes
Current Pharmaceutical Design PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
Current Pharmaceutical Design The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders
Current Pharmaceutical Design Biomarkers in Post-stroke Depression
Current Neurovascular Research Genomics-Based Identification of Molecular Mechanisms behind the Cancer Preventive Action of Phytochemicals: Potential and Challenges
Current Pharmaceutical Biotechnology Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Current Drug Targets Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases
Current Medicinal Chemistry DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics